Literature DB >> 21487813

[Familial pancreatic carcinoma].

F Ehehalt1, R Grützmann.   

Abstract

Less than 10% of pancreatic ductal adenocarcinomas are based on a hereditary syndrome. In contrast a positive family history for pancreatic cancer raises the individual risk for the development of pancreatic and extrapancreatic malignancies.While 70% of hereditary pancreatic carcinomas can be attributed to the familiar pancreatic cancer syndrome 30% are caused by other hereditary syndromes, e.g., Peutz-Jeghers syndrome or familial adenomatous polyposis. Furthermore, genetically determined pancreatitis (e.g., hereditary pancreatitis or cystic fibrosis) can lead to pancreatic cancer.Up to now conclusive data for routine screening of high risk patients are not available which is due in part to the difficult identification of high risk patients and the problematic classification of detected pancreatic lesions. Therefore, high risk patients should be included in controlled clinical trials for screening. Small pancreatic lesions are not clear indications for surgical resection as false positive results can hamper a clear diagnosis and prophylactic pancreatectomy is not recommended. In the case of a histologically proven carcinoma a prophylactic extension of resection might be reasonable. Prevention of familial pancreatic cancer can be achieved through nicotine abstinence.

Entities:  

Mesh:

Year:  2011        PMID: 21487813     DOI: 10.1007/s00104-011-2084-x

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  13 in total

1.  Pancreatic cancer screening in a prospective cohort of high-risk patients: a comprehensive strategy of imaging and genetics.

Authors:  Elizabeth C Verna; Caroline Hwang; Peter D Stevens; Heidrun Rotterdam; Stavros N Stavropoulos; Carolyn D Sy; Martin A Prince; Wendy K Chung; Robert L Fine; John A Chabot; Harold Frucht
Journal:  Clin Cancer Res       Date:  2010-09-28       Impact factor: 12.531

2.  Advances in counselling and surveillance of patients at risk for pancreatic cancer.

Authors:  Randall E Brand; Markus M Lerch; Wendy S Rubinstein; John P Neoptolemos; David C Whitcomb; Ralph H Hruban; Teresa A Brentnall; Henry T Lynch; Marcia I Canto
Journal:  Gut       Date:  2007-10       Impact factor: 23.059

Review 3.  Update on familial pancreatic cancer.

Authors:  Ralph H Hruban; Marcia I Canto; Michael Goggins; Richard Schulick; Alison P Klein
Journal:  Adv Surg       Date:  2010

4.  Anticipation in familial pancreatic cancer.

Authors:  C D McFaul; W Greenhalf; J Earl; N Howes; J P Neoptolemos; R Kress; M Sina-Frey; H Rieder; S Hahn; D K Bartsch
Journal:  Gut       Date:  2005-06-21       Impact factor: 23.059

Review 5.  [Cystic tumors of the pancreas].

Authors:  R Grützmann; H-D Saeger
Journal:  Chirurg       Date:  2010-08       Impact factor: 0.955

6.  Risk factors for the development of pancreatic cancer in familial pancreatic cancer kindreds.

Authors:  Stephen J Rulyak; Albert B Lowenfels; Patrick Maisonneuve; Teresa A Brentnall
Journal:  Gastroenterology       Date:  2003-05       Impact factor: 22.682

Review 7.  [Hereditary pancreatic cancer].

Authors:  N Habbe; P Langer; D K Bartsch
Journal:  Chirurg       Date:  2008-11       Impact factor: 0.955

8.  Prevalence of familial pancreatic cancer in Germany.

Authors:  Detlef K Bartsch; Ralf Kress; Mercedes Sina-Frey; Robert Grützmann; Berthold Gerdes; Christian Pilarsky; Joachim W Heise; Klaus-Martin Schulte; Mario Colombo-Benkmann; Cristina Schleicher; Helmut Witzigmann; Olaf Pridöhl; Michael B Ghadimi; Olaf Horstmann; Wolfgang von Bernstorff; Lisa Jochimsen; Jan Schmidt; Sven Eisold; Lope Estévéz-Schwarz; Stephan A Hahn; Karsten Schulmann; Wolfgang Böck; Thomas M Gress; Nikolaus Zügel; Karl Breitschaft; Klaus Prenzel; Helmut Messmann; Esther Endlicher; Margarete Schneider; Andreas Ziegler; Wolff Schmiegel; Helmut Schäfer; Matthias Rothmund; Harald Rieder
Journal:  Int J Cancer       Date:  2004-07-20       Impact factor: 7.396

9.  Five years of prospective screening of high-risk individuals from families with familial pancreatic cancer.

Authors:  P Langer; P H Kann; V Fendrich; N Habbe; M Schneider; M Sina; E P Slater; J T Heverhagen; T M Gress; M Rothmund; D K Bartsch
Journal:  Gut       Date:  2009-05-25       Impact factor: 23.059

10.  German national case collection of familial pancreatic cancer - clinical-genetic analysis of the first 21 families.

Authors:  H Rieder; M Sina-Frey; A Ziegler; S A Hahn; E Przypadlo; R Kress; B Gerdes; M Colombo Benkmann; T Eberl; R Grützmann; M Lörken; J Schmidt; D K Bartsch
Journal:  Onkologie       Date:  2002-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.